Department of Pharmaceutics, NIPER-Ahmedabad, Palaj, Opp. Airforce station Headquarter, Gandhinagar, Gujarat, 382355, India.
Department of Biotechnology, NIPER-Ahmedabad, Gandhinagar, Gujarat, 382355, India.
AAPS PharmSciTech. 2020 Jan 3;21(2):45. doi: 10.1208/s12249-019-1585-7.
In order to investigate the possible role of butter oil (BO) and omega-3 fatty acids-rich fish oil (O3FO) in the delivery of donepezil hydrochloride microemulsion (DH-ME) to the brain via intranasal route, the present study was conducted. DH:BO and DH:O3FO binary mixtures (9:1 to 1:9) were prepared by simple physical mixing and subjected to in vitro diffusion study. Ratios of DH:BO and DH:O3FO, which showed the highest diffusion, were selected for further development of microemulsion (ME). Globule sizes of DH-BO-ME and DH-O3FO-ME were found to be 87.66 ± 5.23 nm and 88.59 ± 8.23 nm, respectively. Nasal histopathological study and in vitro cytotoxicity study revealed the safety of the formulation. Higher percentage of nasal diffusion was found with DH-BO-ME (71.22 ± 1.21%) and DH-O3FO-ME (62.16 ± 1.23%) in comparison to DH-ME (59.69 ± 1.74%) and DH solution (55.01 ± 1.19%), which was further supported by in vitro cell permeability study. After intranasal administration, %bioavailability of drug in the rat brain (Sprague-Dawley rats)(on the basis of DH-ME IV) was higher with DH-BO-ME (313.59 ± 12.98%) and DH-O3FO-ME (361.73 ± 15.15%) in comparison to DH-ME (168.62 ± 6.60%) and DH solution (8.960 ± 0.23%). The results of ex vivo diffusion study and in vivo pharmacokinetic study suggested that BO and O3FO helped in enhancing the nasal permeability and the brain uptake of drug when administered intranasally.
为了研究通过鼻内途径给予盐酸多奈哌齐微乳(DH-ME)的可能性,本研究探讨了黄油油(BO)和富含 ω-3 脂肪酸的鱼油(O3FO)在这一过程中可能发挥的作用。通过简单的物理混合制备了 DH:BO 和 DH:O3FO 二元混合物(9:1 至 1:9),并进行了体外扩散研究。选择具有最高扩散率的 DH:BO 和 DH:O3FO 比例进一步开发微乳(ME)。DH-BO-ME 和 DH-O3FO-ME 的粒径分别为 87.66±5.23nm 和 88.59±8.23nm。鼻组织病理学研究和体外细胞毒性研究表明该制剂具有安全性。与 DH-ME(59.69±1.74%)和 DH 溶液(55.01±1.19%)相比,DH-BO-ME(71.22±1.21%)和 DH-O3FO-ME(62.16±1.23%)具有更高的鼻内扩散百分比,这一结果也得到了体外细胞渗透性研究的支持。经鼻给药后,与 DH-ME IV 相比,DH-BO-ME(313.59±12.98%)和 DH-O3FO-ME(361.73±15.15%)在大鼠脑中的药物生物利用度更高,而 DH-ME(168.62±6.60%)和 DH 溶液(8.960±0.23%)。体外扩散研究和体内药代动力学研究结果表明,BO 和 O3FO 有助于增强药物的鼻腔通透性和脑内摄取。